Article: Successful treatment of exfoliative cheilitis with dupilumab: A case report.
SAGE open medical case reports
2023 Volume 11, Page(s) 2050313X231193076
Abstract: This case report describes the first known successful treatment of exfoliative cheilitis with the interleukin-4 receptor alpha antagonist dupilumab in an adult patient. With no response to topical tacrolimus, hydrocortisone, dapsone, crisaborole or ... ...
Abstract | This case report describes the first known successful treatment of exfoliative cheilitis with the interleukin-4 receptor alpha antagonist dupilumab in an adult patient. With no response to topical tacrolimus, hydrocortisone, dapsone, crisaborole or systemic doxycycline, low dose isotretinoin, or methotrexate, she had resolution with off-label dupilumab after 4 months of treatment. |
---|---|
Language | English |
Publishing date | 2023-08-07 |
Publishing country | England |
Document type | Case Reports |
ZDB-ID | 2736953-5 |
ISSN | 2050-313X |
ISSN | 2050-313X |
DOI | 10.1177/2050313X231193076 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.